Tandem Diabetes Care debuts Tandem Mobi
Tandem Diabetes Care, an insulin delivery and diabetes technology company, is introducing Tandem Mobi.
The tool, which the company dubbed, "the world’s smallest, durable automated insulin delivery system for people living with diabetes," aims to help individuals living with diabetes to experience the life-changing benefits of Control-IQ technology, the company said.
Featuring a Control-IQ advanced hybrid closed-loop automated insulin delivery feature, the tool is cleared for use by people with Type 1 diabetes who are aged 6 years old and older. In addition, it works to help predict and prevent high and low blood sugar.
“This tiny, wearable pump exceeded the expectations of users from an early access program, and we are thrilled to begin offering this exciting new technology to more people in the diabetes community,” said John Sheridan, president and CEO. "With this launch, we are executing on our strategy to offer a differentiated portfolio of durable insulin pumps, providing choice, along with new options in wearability.”
Key features in the Tandem Mobi System include:
- Impressively Small – Less than half the size of the t:slim X2 insulin pump and small enough to fit in the coin pocket of a pair of jeans
- Wearability Like Never Before – Can be worn almost anywhere, giving users greater discretion, comfort and options for how they manage their diabetes:
- Wear it on-body with a lightweight adhesive sleeve (sold separately)
- Clip it discreetly to clothing; slip it into a pocket
- Infusion Set Options – Compatible with all existing Tandem-branded infusion sets manufactured by Convatec, including a new 5-inch tubing option made just for Tandem Mobi. Infusion sets allow users to temporarily disconnect from their pump for convenience and provide the flexibility of more than 30 mix-and-match infusion site and tubing length combinations.
- Tandem Mobi Mobile App – Full iOS mobile control through a user’s compatible iPhone5
- Sensor Compatibility – Compatible with the Dexcom G6 Continuous Glucose Monitoring System. Additional CGM sensor integrations are planned, including Dexcom G7 in the second quarter of 2024, followed by integration with the Abbott FreeStyle Libre 3 sensor.
- #1 Rated1 Control-IQ Technology – Uses values from a Dexcom G6 CGM to predict glucose levels 30 minutes ahead and automatically adjust insulin, if needed, to help prevent high and lows
- Clear 200-unit cartridge – Allows users to see their remaining insulin level
- Water-Resistant – The pump is water-resistant to a depth of 8 feet (2.4 meters) for up to 2 hours (IP28 rating)
- Flexible Pump Control – The Tandem Mobi system has a physical button that allows users to deliver a bolus of insulin without their iPhone.
- Advanced Technology – Uses modern wireless charging and is capable of remote software updates
[Read more: Driving innovation in diabetes care]